关注
Neslişah BARLAK
Neslişah BARLAK
在 erzurum.edu.tr 的电子邮件经过验证
标题
引用次数
引用次数
年份
ING5 inhibits cancer aggressiveness by inhibiting Akt and activating p53 in prostate cancer
N Barlak, O Capik, F Sanli, A Kilic, A Aytatli, A Yazici, S Ortucu, M Ittmann, ...
Cell Biology International 44 (1), 242-252, 2020
172020
AZD4547 targets the FGFR/Akt/SOX2 axis to overcome paclitaxel resistance in head and neck cancer
A Aytatli, N Barlak, F Sanli, HO Caglar, B Gundogdu, A Tatar, M Ittmann, ...
Cellular Oncology, 1-16, 2022
162022
The effects of Daucus carota extract against PC3, PNT1a prostate cells, acetylcholinesterase, glutathione S‐transferase, and α‐glycosidase; an in vitro–in silico study
MN Atalar, A Aras, F Türkan, N Barlak, Ü Yildiko, OF Karatas, MH Alma
Journal of Food Biochemistry 45 (12), e13975, 2021
152021
Mode of action of carboplatin via activating p53/miR‐145 axis in head and neck cancers
A Kilic, N Barlak, F Sanli, A Aytatli, O Capik, OF Karatas
The Laryngoscope 130 (12), 2818-2824, 2020
142020
The roles of microRNAs in the stemness of oral cancer cells
N Barlak, O Capik, F Sanli, OF Karatas
Oral Oncology 109, 104950, 2020
122020
MicroRNA‐145 transcriptionally regulates Semaphorin 3A expression in prostate cancer cells
N Barlak, O Capik, A Kilic, F Sanli, A Aytatli, A Yazici, EA Karatas, ...
Cell Biology International 45 (5), 1082-1090, 2021
102021
Comprehensive in silico analysis for identification of novel candidate target genes, including DHX36, OPA1, and SENP2, located on chromosome 3q in head and neck cancers
OF Karatas, O Capik, N Barlak, E Aydin Karatas
Head & Neck 43 (1), 288-302, 2021
52021
MiR-4484 Acts as a Potential Saliva Biomarker for Early Detection of Peri-implantitis.
G Urvasizoglu, A Kilic, N Barlak, M Gundogdu, OF Karatas
International Journal of Oral & Maxillofacial Implants 36 (1), 2021
52021
Current cancer stem cell biomarkers in laryngeal cancer
OF Karatas, N Barlak, H Sahin, H Aydin
The European Research Journal 3 (3), 200-206, 2017
32017
Overexpression of POFUT1 promotes malignant phenotype and mediates perineural invasion in head and neck squamous cell carcinoma
N Barlak, G Kusdemir, R Gumus, B Gundogdu, MH Sahin, A Tatar, ...
Cell biology international 47 (12), 1950-1963, 2023
12023
Expression and prognostic value of ING3 in advanced laryngeal squamous cell carcinoma
N Barlak, G Kuşdemir, R Gumus, A Şahin, B Gündoğdu, ÖF Karatas, ...
The European Research Journal 9 (3), 517-528, 2023
12023
Metformin Treatment Sensitizes Human Laryngeal Cancer Cell Line Hep-2 to 5-Fluorouracil
N Barlak, F Sanli, O Capik, E Tuysuz, E Aydın Karatas, H Turkez, ...
Clinical Cancer Drugs 7 (1), 16-24, 2020
12020
Bioinformatics approach combined with experimental verification reveals OAS3 gene implicated in paclitaxel resistance in head and neck cancer
HO Caglar, A Aytatli, N Barlak, E Aydin Karatas, A Tatar, A Sahin, ...
Head & Neck, 2024
2024
The AKT antagonist AZD5363 suppresses features associated with cancer progression in human larynx cancer cells
F Şanlı, N Barlak, A Kılınç, Ö Çapık, A Aytatlı, OF Karatas
The European Research Journal 6 (5), 380-387, 2020
2020
系统目前无法执行此操作,请稍后再试。
文章 1–14